Welcome to this month’s ADVOCATE BRIEF
Welcome to the Archo Advocacy Newsletter For March 2025!
As we enter March, we look back at February's most prominent healthcare developments. This edition highlights key policy changes, economic trends, community health initiatives, and the latest healthcare technology. These insights will help you stay informed and ahead of the curve, from regulatory shifts to innovative treatments. Let’s dive in!
Healthcare Transformation, Policy Updates, Cost Challenges, & Innovation We Can All Take Action On For The Benefit of Patients!!!
POLICY PULSE: POLITICAL
Shaping the Future of Healthcare Policy
Keeping up with healthcare policy changes is essential for understanding how new regulations and legal battles shape the industry. This month, we explore recent lawsuits, regulatory shifts, and insurer commitments to reform.
Key Insights:
The 340B Reform Battle Continues: Hospitals are resisting J&J’s restrictions on 340B drug pricing and arguing for more transparency in pricing policies.
Cigna's Prior Authorization Overhaul: Following mounting pressure, Cigna vows to reform its prior authorization processes, reducing administrative burdens on patients and providers.
Medicare and Prescription Pricing: New discussions around Medicare’s ability to negotiate drug prices continue to shape the affordability landscape for seniors.
📌 Stay informed on healthcare policy and how Advocacy functions can impact health policy through our eBook, which can be downloaded here.
COST OF CARE: ECONOMIC
The Price of Access: What’s Changing in Healthcare Costs?
From drug pricing reforms to insurance changes, financial accessibility remains a critical concern for patients and healthcare systems alike.
Key Insights:
FDA Greenlights Non-Opioid Pain Treatment: Vertex’s new pain medication offers a promising alternative to opioids, potentially reshaping the market and insurance coverage policies.
Rising Costs in Oncology Care: The long-term impact of high-cost cancer treatments is driving new conversations about affordability and patient financial assistance programs.
Employer-Sponsored Insurance Shifts: New trends indicate employers are reassessing healthcare benefits, with an increased focus on cost-sharing models.
💡 Get expert perspectives on navigating the shifting cost landscape in the Bridging the Gap LinkedIn Group.
COMMUNITY LENS: SOCIOCULTURAL
Addressing Health Disparities in Our Communities
Healthcare is about more than just treatments—it’s about access, equity, and ensuring all communities receive the support they need.
Key Insights:
Novartis Champions Early Cancer Detection: By investing in community-driven screening programs, Novartis aims to improve outcomes for at-risk populations.
Health Equity in Action: New initiatives focus on expanding healthcare enrollment efforts, particularly among underserved communities.
Spotlight on Patient Advocacy: Key healthcare leaders are stepping up to influence policy discussions and drive systemic change.
🌍 Explore ways to engage in health equity initiatives. Find Out More at Archo.io
TECH TRENDS: TECHNOLOGY
How Technology is Transforming Healthcare
With digital health advancements and AI-powered innovations, technology continues to shape the way patients and providers interact.
Key Insights:
EHR Systems Get Smarter: AI-driven enhancements are improving electronic health records, making patient data more accessible and actionable.
Cybersecurity in Healthcare: As data breaches rise, new cybersecurity measures are being implemented to protect sensitive patient information.
Telemedicine’s Expanding Role: Virtual care solutions are now more integrated than ever, reshaping how patients access primary and specialty care.
🚀 Stay ahead with the latest in healthcare technology. Discover more by reaching out to us directly!
📣 Join the Conversation: Follow Archo Advocacy on LinkedIn for real-time updates on healthcare policy, costs, equity, and technology.
📧 Subscribe to Our Newsletter: Never miss an update—sign up for monthly insights into key healthcare trends.
📖 Download our latest white paper from the BIOADVOCATE Benchmark. Developed with a data-driven approach, this report offers the first comprehensive assessment of how advocacy functions are structured, resourced, and integrated within the pharmaceutical and biotech industries. Our findings highlight clear correlations between advocacy investment and improved patient engagement, clinical trial retention, and regulatory success— proving that advocacy is not just a support function but a strategic driver of healthcare transformation. Check out a brief intro to the paper here.
1 For all citations, take a look at the google sheet that you can find at the link below: https://docs.google.com/spreadsheets/d/1DN8QyfRGTCwNOypwUr-a8exTPTiCLh4HzgVhtB_6OOQ/edit?usp=sharing
